These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3110024)

  • 1. Spectrophotometric method for the assay of human blood coagulation factor VIII.
    van Dieijen G; van Dieijen-Visser MP; Franssen J; Hemker HC
    Haemostasis; 1987; 17(1-2):14-24. PubMed ID: 3110024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of coagulation factor VIII activity by a chromogenic substrate method on STA, an automated coagulation analyzer.
    Kleinveld HA; Andersson NE; van Voorthuizen H; den Hartog J; de Groot PG
    Scand J Clin Lab Invest; 1999 Aug; 59(5):335-41. PubMed ID: 10533845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Issues with the assay of factor VIII activity in plasma and factor VIII concentrates.
    Lundblad RL; Kingdon HS; Mann KG; White GC
    Thromb Haemost; 2000 Dec; 84(6):942-8. PubMed ID: 11154139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a simple chromogenic factor VIII assay for clinical use.
    Wagenvoord RJ; Hendrix HH; Hemker HC
    Haemostasis; 1989; 19(4):196-204. PubMed ID: 2509307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of porcine factor VIII:C by thrombin and factor Xa.
    Lollar P; Knutson GJ; Fass DN
    Biochemistry; 1985 Dec; 24(27):8056-64. PubMed ID: 3937553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple and accurate microplate assay for the determination of factor VIII activity.
    Carlebjörk G; Oswaldsson U; Rosén S
    Thromb Res; 1987 Jul; 47(1):5-14. PubMed ID: 3116712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural and functional characteristics of the B-domain-deleted recombinant factor VIII protein, r-VIII SQ.
    Sandberg H; Almstedt A; Brandt J; Gray E; Holmquist L; Oswaldsson U; Sebring S; Mikaelsson M
    Thromb Haemost; 2001 Jan; 85(1):93-100. PubMed ID: 11204595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical application of a chromogenic substrate method for determination of factor VIII activity.
    Rosén S; Andersson M; Blombäck M; Hägglund U; Larrieu MJ; Wolf M; Boyer C; Rothschild C; Nilsson IM; Sjörin E
    Thromb Haemost; 1985 Dec; 54(4):818-23. PubMed ID: 3937277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of clotting factor VIII activity in mammals using the one-stage clotting and the chromogenic methods].
    Lutze G; Lutze G; Kutschmann K; Schröpel M
    Berl Munch Tierarztl Wochenschr; 2002; 115(7-8):297-302. PubMed ID: 12174728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of factor VIII in the activation of human blood coagulation factor X by activated factor IX.
    Mertens K; van Wijngaarden A; Bertina RM
    Thromb Haemost; 1985 Oct; 54(3):654-60. PubMed ID: 3937263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Room temperature, microtray chromogenic assay of factor VIII:C.
    Prowse C; Hornsey V; McKay G; Waterston Y
    Vox Sang; 1986; 50(1):21-5. PubMed ID: 3082074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of human factor VIII in factor X activation.
    Hultin MB
    J Clin Invest; 1982 Apr; 69(4):950-8. PubMed ID: 6804496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor VIII assay mimicking in vivo coagulation conditions.
    Kusch M; Grundmann C; Keitel S; König H
    Haemophilia; 2014 Mar; 20(2):e164-70. PubMed ID: 24286249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factor IXa protects activated factor VIII against inactivation by activated protein C.
    Bertina RM; Cupers R; van Wijngaarden A
    Biochem Biophys Res Commun; 1984 Nov; 125(1):177-83. PubMed ID: 6439201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissociation of the Factor-VIII complex during clotting: role of thrombin and phospholipids.
    Muntean W; Rothwangl HJ
    Eur J Clin Invest; 1984 Dec; 14(6):462-8. PubMed ID: 6441724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Glu113Ala mutation within a factor VIII Ca2+-binding site enhances cofactor interactions in factor Xase.
    Wakabayashi H; Su YC; Ahmad SS; Walsh PN; Fay PJ
    Biochemistry; 2005 Aug; 44(30):10298-304. PubMed ID: 16042406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a sensitive and rapid chromogenic factor IX assay for clinical use.
    Wagenvoord R; Hendrix H; Tran T; Hemker HC
    Haemostasis; 1990; 20(5):276-88. PubMed ID: 2127037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromogenic assays for equine coagulation factors VII, VIII:C, IX, and X, and C1-esterase inhibitor.
    Topper MJ; Prasse KW
    Am J Vet Res; 1998 May; 59(5):538-41. PubMed ID: 9582952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collaborative field study on the utility of a BDD factor VIII concentrate standard in the estimation of BDDr Factor VIII:C activity in hemophilic plasma using one-stage clotting assays.
    Ingerslev J; Jankowski MA; Weston SB; Charles LA;
    J Thromb Haemost; 2004 Apr; 2(4):623-8. PubMed ID: 15102018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromogenic substrate spectrophotometric assays for the measurement of clotting function.
    Aiyappa PA
    Ann N Y Acad Sci; 1981; 370():812-21. PubMed ID: 6943978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.